Read More Pharma Industry News FDA green light fast-tracks Diamyd Medical’s type 1 diabetes verdict by nine months Diamyd Medical accelerates its Phase 3 type 1 diabetes trial after FDA alignment. Find out what the earlier data readout means for approval prospects. byPallavi MadhirajuJanuary 6, 2026